|
|
|
Volumn 323, Issue 7309, 2001, Pages 359-
|
|
Bayer decides to withdraw cholesterol lowering drug
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CERIVASTATIN;
GEMFIBROZIL;
HYPOCHOLESTEROLEMIC AGENT;
PYRIDINE DERIVATIVE;
AGED;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DRUG COMBINATION;
DRUG CONTROL;
HUMAN;
MORTALITY;
POSTMARKETING SURVEILLANCE;
RHABDOMYOLYSIS;
AGED;
ANTICHOLESTEREMIC AGENTS;
DRUG AND NARCOTIC CONTROL;
DRUG THERAPY, COMBINATION;
GEMFIBROZIL;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
PYRIDINES;
RHABDOMYOLYSIS;
|
|
EID: 18044404125
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (60)
|
|
References (0)
|